Voya Investment Management LLC Protagonist Therapeutics, Inc Transaction History

Voya Investment Management LLC

$85.7 Billion
Q2 2024

A detailed history of Voya Investment Management LLC transactions in Protagonist Therapeutics, Inc stock. As of the latest transaction made, Voya Investment Management LLC holds 65,066 shares of PTGX stock, worth $2.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

65,066

Previous 69,443 6.3%

Holding current value

$2.9 Million

Previous $2.01 Million 12.25%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$24.66 - $34.8 $107,936 - $152,319	-4,377 Reduced 6.3%	65,066 $2.25 Million
Q1 2024 May 15, 2024	BUY	$21.79 - $32.15 $570,854 - $842,265	26,198 Added 60.58%	69,443 $2.01 Million
Q4 2023 Feb 14, 2024	BUY	$14.05 - $23.44 $3,962 - $6,610	282 Added 0.66%	43,245 $991,000
Q3 2023 Nov 14, 2023	BUY	$16.68 - $23.66 $22,918 - $32,508	1,374 Added 3.3%	42,963 $716,000
Q2 2023 Aug 14, 2023	SELL	$18.02 - $29.36 $945,473 - $1.54 Million	-52,468 Reduced 55.78%	41,589 $1.15 Million
Q1 2023 May 15, 2023	SELL	$10.78 - $25.38 $488,786 - $1.15 Million	-45,342 Reduced 32.53%	94,057 $2.16 Million
Q4 2022 Feb 14, 2023	SELL	$7.36 - $11.17 $51,961 - $78,860	-7,060 Reduced 4.82%	139,399 $1.52 Million
Q3 2022 Mar 03, 2023	BUY	$7.86 - $11.71 $55,491 - $82,672	7,060 Added 5.06%	146,459 $1.23 Million
Q3 2022 Nov 14, 2022	BUY	$7.86 - $11.71 $1.01 Million - $1.51 Million	129,091 Added 743.27%	146,459 $1.24 Million
Q4 2021 Feb 14, 2022	SELL	$17.63 - $37.1 $1,216 - $2,559	-69 Reduced 0.4%	17,368 $594,000
Q3 2021 Nov 15, 2021	BUY	$12.95 - $49.69 $15,371 - $58,982	1,187 Added 7.3%	17,437 $309,000
Q2 2021 Aug 16, 2021	BUY	$25.57 - $44.88 $29,558 - $51,881	1,156 Added 7.66%	16,250 $729,000
Q1 2021 May 17, 2021	BUY	$19.02 - $31.15 $38,477 - $63,016	2,023 Added 15.48%	15,094 $391,000
Q4 2020 Feb 16, 2021	BUY	$18.49 - $25.13 $56,302 - $76,520	3,045 Added 30.37%	13,071 $264,000
Q3 2020 Nov 16, 2020	BUY	$15.19 - $22.4 $152,294 - $224,582	10,026 New	10,026 $196,000

Others Institutions Holding PTGX

# of Institutions

195

Shares Held

58.7M

Call Options Held

20.8K

Put Options Held

109K

View Full List

About Protagonist Therapeutics, Inc

Ticker PTGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,084,100
Market Cap $2.19B
Description
Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...

More about PTGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.

Account

Voya Investment Management LLC Protagonist Therapeutics, Inc Transaction History